We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

Whitepaper

Novel Technology Expands the Power of DIA-MS

Download this whitepaper to review the exciting technology behind the advances in data independent acquisition and explore how it can enhance your research.
Whitepaper

Batch-to-Batch Consistency of Premium Grade Bioactive Proteins

Many novel cell and gene therapies have the potential to offer personalized therapeutic approaches and hold great promise for curing or treating diseases.
Whitepaper

Non-Invasive Monitoring of Nonalcoholic Steatohepatitis

Nonalcoholic steatohepatitis (NASH) is an aggressive form of nonalcoholic fatty liver disease (NAFLD), a liver condition that is characterized by liver steatosis accompanied by liver cell injury and inflammation.
Whitepaper

Detection Of Low-Abundance Serum Proteins Associated With Prediabetes For Predictive And Prognostic Purposes

Download this whitepaper to uncover predicting disease onset via clinical biomarkers as well as other potential applications in diabetes research.
Whitepaper

Confident RNA Sample Quality Control and Fragment Analysis.

This whitepaper, including 15 peer-reviewed publications across various RNA applications, demonstrates how researchers used automated electrophoresis for sample quality control and fragment analysis to ensure high-quality RNA and cDNA samples.
Whitepaper

The Battle Against COVID-19

The battle against COVID-19 only begins with a test to identify who is infected and who is not. To accelerate an effective response, we have to move beyond the initial diagnosis to prognosis: Who is most susceptible to developing serious, life-threatening symptoms?
Whitepaper

Zeno Trap: Defining New Levels of Sensitivity

Download this whitepaper to discover a system that enhances sensitivity and maintains high resolution, fast scan speed as well as a wide dynamic range.
Whitepaper

Protein Biomarkers Show Promise in Predicting Patient Response to Cancer Immunotherapies

Cancer immunotherapy relies on activating or enhancing the antitumor immune response and has taken a central position in cancer treatment modalities. However, not all patients respond to immunotherapy, and combination immunotherapies increase cost of treatment and heighten the risk for toxicity-related adverse events.
Whitepaper

Accelerating Cancer Immune Cell Therapies

As we have gained a greater understanding of cancer biology, therapeutic interventions have evolved from a one-size-fits-all approach to more targeted approaches, which afford patients not only longer lives but increased quality of life.
Whitepaper

Challenging Host Cell Protein Assays for Improved Risk Mitigation

At high levels, host cell proteins (HCPs) can cause immunogenic responses and reduced efficacy of biologics, so it is imperative to have an effective, robust HCP assay to detect them and mitigate these effects.
Advertisement